Specialty Cardiovascular
-
Featured
DCD Donor Hearts Safely Expand Donor Organ Pool
Massachusetts General Hospital is one of five donation after circulatory death (DCD) heart transplant centers in the U.S., investigating DCD donor hearts for transplantation.
-
Viewpoint: New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes
Plaque erosion deserves more attention as a distinct entity in patients with acute coronary syndromes—notably because it may potentially be managed with antithrombotic therapy alone without stenting, according to Dhaval Kolte, MD, PhD, and Ik-Kyung Jang, MD, PhD, of the Cardiology Division, and a colleague.
-
Reducing Post-Thrombotic Syndrome Through Reperfusion After DVT May Be Time-Sensitive
Farouc Jaffer, MD, PhD, and Wenzhu Li, MD, and colleagues have provided experimental and clinical evidence that the benefit of catheter-based intervention for reducing the post-thrombotic syndrome after acute proximal deep vein thrombosis might depend on how many days have elapsed since symptom onset.
-
Clinical Diagnostic Tools May Misclassify HFpEF in Dyspnea Patients
Heart failure with preserved ejection fraction (HFpEF) can be challenging to diagnose, and recently risk scores have been developed to aid in diagnosis. For patients with chronic dyspnea, clinician-researchers in the Corrigan Minehan Heart Center sound a note of caution about using these scores including the HFA-PEFF algorithm and H2FPEF score to rule out HFpEF.
-
Non–Vitamin K Antagonist Oral Anticoagulants Are Safe for Selected Patients with Postoperative AF
Patrick T. Ellinor, MD, PhD, Steven A. Lubitz, MD, MPH, Thor M. Sundt, MD, and colleagues determined that after cardiac surgery, non–vitamin K antagonist oral anticoagulants are a safe alternative to warfarin for patients with nonvalvular atrial fibrillation who have acceptable bleeding risk.
-
Leveraging Imaging to Prevent Disease
In this video, Michael T. Osborne, MD, of the Corrigan Minehan Heart Center at Massachusetts General Hospital, discusses his research focused on preventing cardiovascular disease before it starts using a systems biology approach.
Cardiovascular contributors
-
Aaron L. Baggish, MD
Director, Cardiovascular Performance Program, Director, Cardiovascular Performance Program Fellowship
Recent Article
Return-to-Play Screening After COVID-19 for All Athletes
-
Ahmed A. Tawakol, MD
Co-Director, Cardiac MR PET CT Program
Recent Article
Review: Multi-tissue, Multimodality Imaging Uncovers Pathophysiologic Link Between Chronic Stress and Cardiovascular Disease
-
Ami B. Bhatt, MD
Director, Mass General Adult Congenital Heart Disease Program, Director, Outpatient Cardiology
Recent Article
A Hybrid Model of In-person and Telemedicine Visits Facilitates Longitudinal Care Delivery
-
Anthony Rosenzweig, MD
Chief, Cardiology Division, Co-Director, Corrigan Minehan Heart Center
Recent Article
Medical Grand Rounds: Cardiac Manifestations of COVID-19
-
Farouc A. Jaffer, MD, PhD
Director, Coronary Intervention, Massachusetts General Hospital, Director, MGH Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) program, Associate Physician, MGH Cardiology, Department of Medicine
Recent Article
Reducing Post-Thrombotic Syndrome Through Reperfusion After DVT May Be Time-Sensitive
-
Hanna K. Gaggin, MD, MPH
Assistant Physician, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Review: Predicting Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction
-
Jagmeet P. Singh, MD, PhD
Attending Physician, Cardiac Arrhythmia Service, Massachusetts General Hospital
Recent Article
CRT Improves Left Ventricular Function for Chemotherapy-Induced Cardiomyopathy Patients
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
TRANSFORM HFrEF Study Aims to Improve HF Outcomes
-
Jason H. Wasfy, MD
Medical Director, Massachusetts General Physicians Organization, Director of Quality and Analytics, Massachusetts General Hospital Heart Center
Recent Article
Role of Cardiologists in Evaluation of Type 2 Myocardial Infarction Unclear
-
Jennifer E. Ho, MD
Cardiologist, Heart Failure and Transplantation Program, Assistant Professor of Medicine, Harvard Medical School
Recent Article
Clinical Diagnostic Tools May Misclassify HFpEF in Dyspnea Patients
-
Kenneth Rosenfield, MD, MHCDS
Section Head, Vascular Medicine and Intervention, Chairman, STEMI & Acute MI Quality Improvement Committee
Recent Article
Mass General Provides Guidance for Anticoagulation in Patients with COVID-19
-
Nasrien E. Ibrahim, MD
Associate Director, Resynchronization & Advanced Cardiac Therapeutics Program
Recent Article
Caution Needed When Interpreting BNP During Sacubitril/Valsartan Treatment
-
Steven A. Lubitz, MD, MPH
Cardiac Electrophysiologist
Recent Article
Non–Vitamin K Antagonist Oral Anticoagulants Are Safe for Selected Patients with Postoperative AF
-
Thoralf M. Sundt, MD
Chief, Division of Cardiac Surgery, Director, Corrigan Minehan Heart Center
Recent Article
Non–Vitamin K Antagonist Oral Anticoagulants Are Safe for Selected Patients with Postoperative AF
-
Tomas G. Neilan, MD, MPH
Director, Cardio-Oncology Program, Massachusetts General Hospital, Co-Director, Cardiac MR PET CT Program
Recent Article
Immune Checkpoint Inhibitor Therapy Increases Risk of Atherosclerotic Cardiovascular Events
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
